home > research channels > sectors > pharma


Latest News
14-Nov-2018 Sun Pharma Posts Rs. 219-cr Q2 Loss on Big Provision
07-Nov-2018 Analysts Downgrade Cipla as Co Hints at Headwinds
26-Oct-2018 Zydus-Heinz India Deal Raises Questions Over Cadila’s Role
25-Oct-2018 Zydus Wellness is New Complan Boy
04-Oct-2018 US May Dilute Norm Used to Delay Generics
  more...
Latest Reports
Nov-18 Performance in-line but outlook tepid - Edelweiss Securities  
Oct-18 US generics – on a marginal recovery path - Motilal Oswal  
Oct-18 2QFY19 Results Preview - HDFC Securities  
Oct-18 Analysis of related party transactions - Edelweiss Securities  
Oct-18 DTAB report puts more risk on the 900+ non-reviewed FDCs - Emkay Research  
  more...

Quarterly Summary September-2018
Desc Current Previous Per.Chg
Sales 34597.2 31320.1 10.5
Otherincome 2834.4 2120.4 33.7
Expense 27696.7 24775.4 11.8
RawMaterial 10702.6 8582.6 24.7
StaffCost 5223.3 4788.7 9.1
ExciseDuty 0.0 0.5 -100.0
OtherExp 8781.0 7509.7 16.9
Interest 1000.3 767.2 30.4
GrossProfit 9237.0 8362.8 10.5
Depreciation 1532.0 1324.4 15.7
Tax 1704.8 1527.3 11.6
NetProfit 5153.9 5512.0 -6.5
Total.Comp 90 -- --
Source: ETIG Database

Sectoral Companies As on 14 Nov 2018
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 124847.58
Aurobindo Ph 45858.39
Cipla 41881.05
Piramal Entp 41812.72
Dr.Reddy's 40645.76
Divi's Lab 39931.64
Lupin 38047.79
Cadila Healt 37902.49
Biocon 37491.00
Torrent Phar 27868.00
GlaxoSmith.P 23087.19
Alkem Labora 23053.42
Glenmark Pha 18484.10
  click here for the complete list